Thameus SA
Thameus reported total assets of 502,659 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of Thameus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Thameus's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
Thameus's financial analysis
- Solvency83.4%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Thameus
Thameus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1008.238.883
- VAT number
- BE1008238883
- Peppol
- Registered · 0208:1008238883 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 10 Apr 2024
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Thameus (SA) has been based in Liège since 2024, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 120,416 € and equity of 419,327 €; its revenue is not published. Its solvency stands at 83.4%, above the median of its sector (34.4%).
Companies similar to Thameus
Companies in the same business, of comparable size and area, outside its group.
- Belgica Manufacture of pharmaceutical preparations Ghent · balance sheet 567,720 €
- Prieka Manufacture of pharmaceutical preparations Etterbeek · balance sheet 440,325 €
- Parabolic Biologicals Manufacture of pharmaceutical preparations Namur · balance sheet 132,669 €
- NAQI Manufacture of pharmaceutical preparations Halen · balance sheet €1.25m
- AdipoPharma Belgique Manufacture of pharmaceutical preparations Charleroi · balance sheet 398,195 €
- Orca Consulting Manufacture of pharmaceutical preparations Kapellen · balance sheet 347,741 €
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
- BelCoPhar Manufacture of pharmaceutical preparations Kalmthout · balance sheet 224,468 €
Frequently asked questions about Thameus
What is the revenue of Thameus?
Thameus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Thameus?
In Belgium, the VAT number is the company number prefixed with BE: BE1008238883 for Thameus, if the company is VAT-registered. Its company number (CBE) is 1008.238.883.
Where is the registered office of Thameus?
According to the CBE register, the registered office of Thameus is in 4000 Liège.
What is the equity of Thameus?
At the close of the 2025 financial year, the equity of Thameus amounts to 419,327 €, a solvency of 83.4% of total assets.
Who manages Thameus?
The register lists 7 active mandates at Thameus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Thameus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →